期刊文献+

稳定表达α-Synuclein 4种选择性剪接异构体的PC12细胞对神经毒性剂MPP^+的敏感性研究 被引量:1

Study on the sensitivity of the PC12 cells expressing four α-synuclein isoforms to MPP^+
下载PDF
导出
摘要 目的研究稳定表达α-synuclein 4种选择性剪接体的PC12细胞对神经毒性剂MPP+的敏感性。方法 PCR获得α-synuclein的4个选择性剪切体,克隆入pcDNA3.1载体,转染PC12细胞,经G418筛选获得稳定表达这4个剪切体的PC12细胞株,采用细胞毒的方法检测这4个稳定细胞株对神经毒性剂MPP+的敏感性。结果同全长相比,去除外显子5的选择性剪切体α-synuclein114和α-synuclein98对神经毒性剂MPP+的敏感性升高,表现为细胞活力的降低。结论去除外显子5的选择性剪切体α-synuclein114和α-synu-clein98对神经毒性剂MPP+的敏感性明显升高。抑制外显子5的选择性剪切,从而抑制选择性剪切异构体α-synucle-in114和α-synuclein98的产生可能是阻止神经元退行性丢失的一种策略。 Aim To study the sensitivity of the PC12 cells expressing four α-syn isoforms to MPP+. Meth- ods Four α-syn isoforms was cloned by PCR method, followed by subcloning into the pcDNA3. 1 eukaryotic expression vector. Four obtained recombination plas- mids were transfected into PC12 cells using Lipo- fectamine 2000 respectively. The protein expressions of these four isoforms were identified by WB. Results When exposed to MPP + , these cell lines which overexpressed exon 5-lacking form of α-syn isoforms showed the toxicity to PC12 cells. Conclusion The inhibition of alternative splicing to α-syn exon 5 can reduce the production of α-syn 112 and α-syn 98, which may be a good strategy for rescuing dopaminergic neurons from exposure to neurotoxic agents.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第6期814-817,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81274122 81102831 81073078 30973887 U832008) 国家科技重大专项(No2012ZX09301002-004) 教育部创新团队 天然药物中活性物质的结构与功能研究(No IRT1007) 高等学校博士学科点专项科研基金新教师类资助课题(No20121106120056) 北京市重点实验室 新的药物作用和药理评价(No BZ0150)
关键词 Α-SYNUCLEIN 异构体 MPP+ PC12细胞 敏感性 帕金 森病 α-synuclein isoforms MPP+ PC12 cells sensitivity Parkinson's disease
  • 相关文献

参考文献15

  • 1Xia Y, Saitoh T, Ueda K, et al. Characterization of the human al- pha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms [J]. J Alzheimers Dis, 2001, 3(5) :485 -94.
  • 2Beyer K, Domingo-Sabat M, Lao J I, et al. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases [ J]. Neurogenetics, 2008, 9( 1 ) :15 -23.
  • 3Ueda K, Saitoh T, Mori H. Tissue-dependent altemative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid [J]. Biochem Biophys Res Commun, 1994, 205(2) :1366 -72.
  • 4Murray I V, Giasson B I, Quinn S M, et al. Role of alpha-synu- clein carboxy-terminus on fibril formation in vitro [ J ]. Biochemis- try, 2003, 42 ( 28 ) : 8530 - 40.
  • 5Ma K L, Yuan Y H, Song L K, et al. Over-expression of alpha- synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone[ J ]. Neurosci Lett, 2011, 491 (2) :148 -52.
  • 6MaKL, SongLK, LongWA, et al. Deletion inexon5 of the SNCA gene and exposure to rotenone leads to oligomerization of al- pha-synuclein and toxicity to PC12 cells [J]. Brain Res Bull, 2013, 90:127-31.
  • 7Maroteanx L, Campanelli J T, Scheller R H. Synuclein: a neu- ron-specific protein localized to the nucleus and presynaptic nerve terminal [J]. J Neurosci, 1988, 8(8) :2804 - 15.
  • 8Li W, West N, Colla E, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations [J]. Proc Natl Acad Sci U S A, 2005, 102(6) :2162 -7.
  • 9Beyer K, Humbert J, Fetter A, et al. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease [J]. Neuroreport, 2006, 17(12) :1327 -30.
  • 10Beyer K, Lao J 1, Carrato C, et al. Differential expression of al- pha-synuclein isoforms in dementia with Lewy bodies [ J ]. Neuro- pathol Appl Neurobiol, 2004, 30 (6) :601 - 7.

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部